Apimeds Pharmaceuticals US, Inc. APUS
$7.25
+47.36%
at last close
Financials (TTM)
Trailing-twelve-month financial statements are not available for Apimeds Pharmaceuticals US, Inc. (APUS) — this is common for ETFs and funds, which report holdings rather than income statements. See the overview page for price history and key stats.
Key Stats
- Last Close
- $7.25
- Market Cap
- $7.42 million
- 52-Week Range
- $1.51 – $59.70
- Average Volume
- 4.35 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.